Larimar Therapeutics Inc. (LRMR) NASDAQ
$6.03 (0.43) (-6.66%)
Market Cap: $412.15M
As of 04/25/24 09:37 AM EDT. Market open.
Larimar Therapeutics Inc. (LRMR)
NASDAQ
$6.03
(0.43) (-6.66%)
Market Cap: $412.15M
As of 04/25/24 09:37 AM EDT. Market open.
Add to Portfolio
larimar therapeutics, inc. (nasdaq:lrmr), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. the company’s lead compound, cti-1601, is currently being evaluated in a phase 1 clinical program as a potential treatment for friedreich’s ataxia, a rare and progressive genetic disease. larimar also plans to use its intracellular delivery platform ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
36
Address
Three Bala Plaza East. Suite 506, Pennsylvania, Bala Cynwyd, 19004.
PRICE CHART FOR LARIMAR THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$6.03
Previous Close
$6.46
Days Range
$6.33 - $6.50
52 week range
$2.18 - $13.68
Volume
12,564
Avg. Volume (30 days)
377,563
Market Cap
$412.15M
Dividend Yield
-
P/E
-
Shares Outstanding
63,800,017
Open
$6.03
Previous Close
$6.46
Days Range
$6.33 - $6.50
52 week range
$2.18 - $13.68
Volume
12,564
Avg. Volume (30 days)
377,563
Market Cap
$412.15M
Dividend Yield
-
P/E
-
Shares Outstanding
63,800,017
FINANCIAL STATEMENTS FOR LARIMAR THERAPEUTICS INC
LOADING...
INSIDER TRANSACTIONS FOR LARIMAR THERAPEUTICS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Flynn James E | Director | Feb 16, 2024 | Buy | $8.74 | 1,430,205 | 12,499,991 | 4,207,982 | Feb 16, 2024, 02:37 PM |
Flynn James E | Director | Feb 16, 2024 | Buy | $8.74 | 1,430,206 | 12,500,000 | 6,151,406 | Feb 16, 2024, 02:37 PM |
Flynn James E | Director | Feb 16, 2024 | Buy | $8.74 | 1,430,206 | 12,500,000 | 6,151,389 | Feb 16, 2024, 02:37 PM |
THOMAS FRANK E | Director | Feb 14, 2024 | Buy | $11.00 | 2,000 | 22,000 | 2,000 | Feb 15, 2024, 04:21 PM |
Shankar Gopi | Chief Development Officer | Dec 07, 2023 | Buy | $3.73 | 5,000 | 18,662 | 5,000 | Dec 08, 2023, 04:08 PM |
Celano Michael | Chief Financial Officer | May 17, 2023 | Buy | $3.73 | 5,000 | 18,632 | 112,746 | May 18, 2023, 02:13 PM |
BEN-MAIMON CAROLE | President and CEO | May 17, 2023 | Buy | $3.70 | 5,000 | 18,525 | 266,829 | May 18, 2023, 02:13 PM |
Truitt Joseph | Director | May 17, 2023 | Buy | $3.73 | 2,750 | 10,258 | 2,750 | May 18, 2023, 02:12 PM |
Flynn James E | Director | Sep 16, 2022 | Buy | $3.15 | 2,777,777 | 8,749,998 | 2,777,777 | Sep 20, 2022, 08:31 PM |
Flynn James E | Director | Sep 16, 2022 | Buy | $3.15 | 2,777,777 | 8,749,998 | 4,721,197 | Sep 20, 2022, 08:31 PM |
Flynn James E | Director | Sep 16, 2022 | Buy | $3.15 | 2,777,777 | 8,749,998 | 4,721,200 | Sep 20, 2022, 08:31 PM |
Flynn James E | Director | Sep 16, 2022 | Buy | $3.15 | 2,777,777 | 8,749,998 | 4,721,183 | Sep 20, 2022, 08:31 PM |
Hamilton Thomas Edward | Director | Sep 16, 2022 | Buy | $3.15 | 317,460 | 999,999 | 507,590 | Sep 20, 2022, 06:54 AM |
Celano Michael | Chief Financial Officer | Sep 16, 2022 | Buy | $3.15 | 31,746 | 100,000 | 31,746 | Sep 19, 2022, 07:00 AM |
BEN-MAIMON CAROLE | President and CEO | Sep 16, 2022 | Buy | $3.15 | 31,746 | 100,000 | 56,829 | Sep 19, 2022, 07:00 AM |
Flynn James E | Director | Jun 30, 2021 | Buy | $8.75 | 228,570 | 1,999,988 | 1,943,420 | Jul 02, 2021, 05:07 PM |
Flynn James E | Director | Jun 30, 2021 | Buy | $8.75 | 228,571 | 1,999,996 | 1,943,423 | Jul 02, 2021, 05:07 PM |
Flynn James E | Director | Jun 30, 2021 | Buy | $8.75 | 228,569 | 1,999,979 | 1,943,406 | Jul 02, 2021, 05:07 PM |
Hamilton Thomas Edward | Director | Jun 30, 2021 | Buy | $8.75 | 56,710 | 496,213 | 190,130 | Jul 02, 2021, 04:08 PM |
LAMATTINA JOHN L | Director | Jan 24, 2019 | Option Exercise | $4.38 | 10,844 | 47,497 | 31,376 | Jan 28, 2019, 07:01 PM |
PEREZ ROBERT J | Director | Jan 24, 2019 | Option Exercise | $4.38 | 4,423 | 19,373 | 5,322 | Jan 28, 2019, 07:01 PM |
Hughes Thomas E. | See Remarks | Jun 28, 2018 | Sale | $10.00 | 32,000 | 320,000 | 125,247 | Jun 29, 2018, 07:01 PM |
Hughes Thomas E. | See Remarks | Mar 07, 2018 | Sale | $10.00 | 5,000 | 50,000 | 157,247 | Mar 09, 2018, 06:00 PM |
Daniel Thomas O | Director | Jan 03, 2018 | Option Exercise | $5.18 | 8,687 | 44,999 | 19,452 | Jan 05, 2018, 05:02 PM |
LAMATTINA JOHN L | Director | Jan 03, 2018 | Option Exercise | $5.18 | 9,169 | 47,495 | 20,532 | Jan 05, 2018, 05:01 PM |
Heller Frances K | Director | Oct 13, 2017 | Buy | $3.90 | 10,000 | 38,988 | 47,961 | Oct 17, 2017, 05:11 PM |
KIM DENNIS D | Chief Medical Officer | Jul 11, 2017 | Buy | $3.39 | 10,000 | 33,900 | 21,443 | Jul 12, 2017, 04:05 PM |
Hughes Thomas E. | President and CEO | May 11, 2017 | Option Exercise | $0.80 | 93,211 | 74,673 | 157,371 | May 15, 2017, 08:22 PM |
KIM DENNIS D | Chief Medical Officer | May 11, 2017 | Buy | $4.40 | 9,800 | 43,120 | 11,443 | May 11, 2017, 06:59 PM |
KIM DENNIS D | Chief Medical Officer | May 10, 2017 | Buy | $4.40 | 200 | 880 | 1,643 | May 11, 2017, 06:59 PM |
Daniel Thomas O | Director | Feb 13, 2017 | Option Exercise | $4.18 | 10,765 | 44,998 | 10,765 | Feb 14, 2017, 08:14 PM |
LAMATTINA JOHN L | Director | Feb 13, 2017 | Option Exercise | $4.18 | 11,363 | 47,497 | 11,363 | Feb 14, 2017, 08:07 PM |
Heller Frances K | Director | Dec 19, 2016 | Buy | $3.23 | 10,000 | 32,290 | 30,000 | Dec 20, 2016, 05:02 PM |
Heller Frances K | Director | Nov 15, 2016 | Buy | $3.54 | 10,000 | 35,434 | 20,000 | Nov 17, 2016, 05:00 PM |
Hughes Thomas E. | President and CEO | Aug 29, 2016 | Buy | $3.00 | 10,000 | 29,987 | 63,936 | Aug 31, 2016, 04:15 PM |
Flynn James E | 10% Owner | Jul 20, 2016 | Sale | $3.31 | 901,430 | 2,985,356 | 1,151,802 | Aug 01, 2016, 07:14 PM |
Flynn James E | 10% Owner | Jul 20, 2016 | Sale | $3.31 | 246,439 | 816,157 | 314,889 | Aug 01, 2016, 07:14 PM |
Flynn James E | 10% Owner | Jul 20, 2016 | Sale | $3.31 | 193,630 | 641,264 | 247,413 | Aug 01, 2016, 07:14 PM |
Hughes Thomas E. | President and CEO | Jul 22, 2016 | Option Exercise | $0.75 | 25,000 | 18,750 | 48,936 | Jul 26, 2016, 05:14 PM |
Hughes Thomas E. | President and CEO | Jul 22, 2016 | Buy | $3.02 | 5,000 | 15,104 | 53,936 | Jul 26, 2016, 05:14 PM |
Allen Patricia L | Chief Financial Officer | Jul 26, 2016 | Buy | $3.15 | 8,200 | 25,830 | 19,793 | Jul 26, 2016, 05:10 PM |
Allen Patricia L | Chief Financial Officer | Jul 25, 2016 | Buy | $3.08 | 7,800 | 24,032 | 11,593 | Jul 26, 2016, 05:10 PM |
Heller Frances K | Director | Jul 22, 2016 | Buy | $2.99 | 10,000 | 29,900 | 10,000 | Jul 26, 2016, 05:09 PM |
PEREZ ROBERT J | Director | Jan 07, 2016 | Option Exercise | $6.29 | 5,564 | 34,998 | 5,564 | Apr 12, 2016, 09:00 PM |
McDonough Cameron Geoffrey | Director | Apr 01, 2016 | Option Exercise | $7.91 | 4,424 | 34,994 | 0 | Apr 04, 2016, 09:00 PM |
Flynn James E | 10% Owner | Feb 12, 2016 | Buy | $6.25 | 13,872 | 86,653 | 2,053,232 | Feb 17, 2016, 02:02 PM |
Flynn James E | 10% Owner | Feb 12, 2016 | Buy | $6.25 | 28,377 | 177,260 | 561,328 | Feb 17, 2016, 02:02 PM |
Flynn James E | 10% Owner | Feb 12, 2016 | Buy | $6.25 | 22,296 | 139,274 | 441,043 | Feb 17, 2016, 02:02 PM |
Flynn James E | 10% Owner | Feb 10, 2016 | Buy | $6.23 | 32,501 | 202,556 | 2,038,856 | Feb 11, 2016, 08:21 PM |
Flynn James E | 10% Owner | Feb 10, 2016 | Buy | $6.23 | 66,486 | 414,361 | 531,921 | Feb 11, 2016, 08:21 PM |
Flynn James E | 10% Owner | Feb 10, 2016 | Buy | $6.23 | 52,239 | 325,569 | 417,937 | Feb 11, 2016, 08:21 PM |
Flynn James E | 10% Owner | Feb 09, 2016 | Buy | $5.73 | 24,484 | 140,271 | 2,006,355 | Feb 11, 2016, 08:21 PM |
Flynn James E | 10% Owner | Feb 11, 2016 | Buy | $6.19 | 504 | 3,119 | 2,039,360 | Feb 11, 2016, 08:21 PM |
Flynn James E | 10% Owner | Feb 09, 2016 | Buy | $5.73 | 50,086 | 286,948 | 465,435 | Feb 11, 2016, 08:21 PM |
Flynn James E | 10% Owner | Feb 11, 2016 | Buy | $6.19 | 1,030 | 6,374 | 532,951 | Feb 11, 2016, 08:21 PM |
Flynn James E | 10% Owner | Feb 09, 2016 | Buy | $5.73 | 39,353 | 225,457 | 365,698 | Feb 11, 2016, 08:21 PM |
Flynn James E | 10% Owner | Feb 11, 2016 | Buy | $6.19 | 810 | 5,013 | 418,747 | Feb 11, 2016, 08:21 PM |
Barrett Peter | Director | Jan 25, 2016 | Option Exercise | $7.91 | 8,849 | 69,996 | 4,643,327 | Jan 27, 2016, 09:19 PM |
McDonough Cameron Geoffrey | Director | Jan 25, 2016 | Option Exercise | $7.91 | 4,424 | 34,994 | 4,424 | Jan 27, 2016, 09:18 PM |
Booth Bruce | Director | Jan 25, 2016 | Option Exercise | $7.91 | 4,424 | 34,994 | 4,638,028 | Jan 27, 2016, 09:18 PM |
Hughes Thomas E. | Chief Executive Officer | Jan 08, 2016 | Option Exercise | $0.75 | 10,000 | 7,500 | 21,320 | Jan 08, 2016, 06:53 PM |
PEREZ ROBERT J | Director | Oct 28, 2015 | Option Exercise | $10.45 | 899 | 9,395 | 899 | Oct 30, 2015, 05:01 PM |
KIM DENNIS D | Chief Medical Officer | Sep 17, 2015 | Sale | $40.00 | 9,142 | 365,680 | 0 | Oct 20, 2015, 08:01 PM |
KIM DENNIS D | Chief Medical Officer | Sep 15, 2015 | Sale | $40.00 | 30,265 | 1,210,600 | 0 | Oct 20, 2015, 08:01 PM |
KIM DENNIS D | Chief Medical Officer | Sep 14, 2015 | Sale | $40.00 | 593 | 23,720 | 0 | Oct 20, 2015, 08:00 PM |
STARR KEVIN P | Director | Sep 24, 2015 | Sale | $43.90 | 136,579 | 5,995,403 | 272,001 | Sep 25, 2015, 04:38 PM |
Hughes Thomas E. | Chief Executive Officer | Sep 23, 2015 | Option Exercise | $0.75 | 10,500 | 7,875 | 11,320 | Sep 24, 2015, 09:00 PM |
Hughes Thomas E. | Chief Executive Officer | Sep 18, 2015 | Option Exercise | $2.45 | 23,126 | 56,659 | 23,946 | Sep 21, 2015, 09:02 PM |
Hughes Thomas E. | Chief Executive Officer | Sep 17, 2015 | Option Exercise | $2.45 | 4,874 | 11,941 | 23,320 | Sep 21, 2015, 09:02 PM |
Hughes Thomas E. | Chief Executive Officer | Sep 17, 2015 | Sale | $40.00 | 22,500 | 900,000 | 820 | Sep 21, 2015, 09:02 PM |
Hughes Thomas E. | Chief Executive Officer | Sep 18, 2015 | Sale | $45.00 | 23,126 | 1,040,670 | 820 | Sep 21, 2015, 09:02 PM |
Goldberg Avi Y. | Director | Sep 18, 2015 | Sale | $45.00 | 5,000 | 225,000 | 53,734 | Sep 21, 2015, 09:01 PM |
Secor Alicia | Chief Commercial Officer | Sep 17, 2015 | Option Exercise | $9.67 | 25,000 | 241,750 | 26,256 | Sep 21, 2015, 09:00 PM |
Secor Alicia | Chief Commercial Officer | Sep 17, 2015 | Sale | $41.05 | 26,256 | 1,077,809 | 1,256 | Sep 21, 2015, 09:00 PM |
KIM DENNIS D | Chief Medical Officer | Sep 17, 2015 | Option Exercise | $1.57 | 9,142 | 14,353 | 9,142 | Sep 17, 2015, 09:00 PM |
KIM DENNIS D | Chief Medical Officer | Sep 15, 2015 | Option Exercise | $1.57 | 30,265 | 47,516 | 30,265 | Sep 17, 2015, 09:00 PM |
KIM DENNIS D | Chief Medical Officer | Sep 17, 2015 | Sale | $40.00 | 9,142 | 365,680 | 0 | Sep 17, 2015, 09:00 PM |
KIM DENNIS D | Chief Medical Officer | Sep 15, 2015 | Sale | $40.00 | 30,265 | 1,210,600 | 0 | Sep 17, 2015, 09:00 PM |
KIM DENNIS D | Chief Medical Officer | Sep 14, 2015 | Option Exercise | $1.57 | 593 | 931 | 593 | Sep 16, 2015, 09:48 PM |
KIM DENNIS D | Chief Medical Officer | Sep 14, 2015 | Sale | $40.00 | 593 | 23,720 | 0 | Sep 16, 2015, 09:48 PM |
Goldberg Avi Y. | Director | Jun 10, 2015 | Sale | $35.00 | 3,000 | 105,000 | 58,734 | Jun 12, 2015, 06:24 PM |
Goldberg Avi Y. | Director | Jun 01, 2015 | Sale | $32.23 | 2,000 | 64,452 | 61,734 | Jun 03, 2015, 07:05 PM |
STARR KEVIN P | Director | Jan 08, 2015 | Option Exercise | $40.04 | 1,248 | 49,970 | 9,356 | Jan 12, 2015, 07:44 PM |
Booth Bruce | Director | Jan 08, 2015 | Option Exercise | $40.04 | 874 | 34,995 | 5,633,604 | Jan 12, 2015, 07:41 PM |
Barrett Peter | Director | Jan 08, 2015 | Option Exercise | $40.04 | 1,748 | 69,990 | 5,634,478 | Jan 12, 2015, 07:39 PM |
Secor Alicia | Chief Commercial Officer | Jun 19, 2014 | Buy | $20.00 | 4,000 | 80,000 | 4,000 | Jun 23, 2014, 05:52 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Flynn James E | Director | 02/16/2024 | 12,499,991 |
Flynn James E | Director | 02/16/2024 | 12,500,000 |
Flynn James E | Director | 02/16/2024 | 12,500,000 |
THOMAS FRANK E | Director | 02/14/2024 | 22,000 |
Shankar Gopi | Chief Development Officer | 12/07/2023 | 18,662 |
Celano Michael | Chief Financial Officer | 05/17/2023 | 18,632 |
BEN-MAIMON CAROLE | President and CEO | 05/17/2023 | 18,525 |
Truitt Joseph | Director | 05/17/2023 | 10,258 |
Flynn James E | Director | 09/16/2022 | 8,749,998 |
Flynn James E | Director | 09/16/2022 | 8,749,998 |
Flynn James E | Director | 09/16/2022 | 8,749,998 |
Flynn James E | Director | 09/16/2022 | 8,749,998 |
Hamilton Thomas Edward | Director | 09/16/2022 | 999,999 |
Celano Michael | Chief Financial Officer | 09/16/2022 | 100,000 |
BEN-MAIMON CAROLE | President and CEO | 09/16/2022 | 100,000 |
Flynn James E | Director | 06/30/2021 | 1,999,988 |
Flynn James E | Director | 06/30/2021 | 1,999,996 |
Flynn James E | Director | 06/30/2021 | 1,999,979 |
Hamilton Thomas Edward | Director | 06/30/2021 | 496,213 |
LAMATTINA JOHN L | Director | 01/24/2019 | 47,497 |
PEREZ ROBERT J | Director | 01/24/2019 | 19,373 |
Hughes Thomas E. | See Remarks | 06/28/2018 | 320,000 |
Hughes Thomas E. | See Remarks | 03/07/2018 | 50,000 |
Daniel Thomas O | Director | 01/03/2018 | 44,999 |
LAMATTINA JOHN L | Director | 01/03/2018 | 47,495 |
Heller Frances K | Director | 10/13/2017 | 38,988 |
KIM DENNIS D | Chief Medical Officer | 07/11/2017 | 33,900 |
Hughes Thomas E. | President and CEO | 05/11/2017 | 74,673 |
KIM DENNIS D | Chief Medical Officer | 05/11/2017 | 43,120 |
KIM DENNIS D | Chief Medical Officer | 05/10/2017 | 880 |
Daniel Thomas O | Director | 02/13/2017 | 44,998 |
LAMATTINA JOHN L | Director | 02/13/2017 | 47,497 |
Heller Frances K | Director | 12/19/2016 | 32,290 |
Heller Frances K | Director | 11/15/2016 | 35,434 |
Hughes Thomas E. | President and CEO | 08/29/2016 | 29,987 |
Flynn James E | 10% Owner | 07/20/2016 | 2,985,356 |
Flynn James E | 10% Owner | 07/20/2016 | 816,157 |
Flynn James E | 10% Owner | 07/20/2016 | 641,264 |
Hughes Thomas E. | President and CEO | 07/22/2016 | 18,750 |
Hughes Thomas E. | President and CEO | 07/22/2016 | 15,104 |
Allen Patricia L | Chief Financial Officer | 07/26/2016 | 25,830 |
Allen Patricia L | Chief Financial Officer | 07/25/2016 | 24,032 |
Heller Frances K | Director | 07/22/2016 | 29,900 |
PEREZ ROBERT J | Director | 01/07/2016 | 34,998 |
McDonough Cameron Geoffrey | Director | 04/01/2016 | 34,994 |
Flynn James E | 10% Owner | 02/12/2016 | 86,653 |
Flynn James E | 10% Owner | 02/12/2016 | 177,260 |
Flynn James E | 10% Owner | 02/12/2016 | 139,274 |
Flynn James E | 10% Owner | 02/10/2016 | 202,556 |
Flynn James E | 10% Owner | 02/10/2016 | 414,361 |
Flynn James E | 10% Owner | 02/10/2016 | 325,569 |
Flynn James E | 10% Owner | 02/09/2016 | 140,271 |
Flynn James E | 10% Owner | 02/11/2016 | 3,119 |
Flynn James E | 10% Owner | 02/09/2016 | 286,948 |
Flynn James E | 10% Owner | 02/11/2016 | 6,374 |
Flynn James E | 10% Owner | 02/09/2016 | 225,457 |
Flynn James E | 10% Owner | 02/11/2016 | 5,013 |
Barrett Peter | Director | 01/25/2016 | 69,996 |
McDonough Cameron Geoffrey | Director | 01/25/2016 | 34,994 |
Booth Bruce | Director | 01/25/2016 | 34,994 |
Hughes Thomas E. | Chief Executive Officer | 01/08/2016 | 7,500 |
PEREZ ROBERT J | Director | 10/28/2015 | 9,395 |
KIM DENNIS D | Chief Medical Officer | 09/17/2015 | 365,680 |
KIM DENNIS D | Chief Medical Officer | 09/15/2015 | 1,210,600 |
KIM DENNIS D | Chief Medical Officer | 09/14/2015 | 23,720 |
STARR KEVIN P | Director | 09/24/2015 | 5,995,403 |
Hughes Thomas E. | Chief Executive Officer | 09/23/2015 | 7,875 |
Hughes Thomas E. | Chief Executive Officer | 09/18/2015 | 56,659 |
Hughes Thomas E. | Chief Executive Officer | 09/17/2015 | 11,941 |
Hughes Thomas E. | Chief Executive Officer | 09/17/2015 | 900,000 |
Hughes Thomas E. | Chief Executive Officer | 09/18/2015 | 1,040,670 |
Goldberg Avi Y. | Director | 09/18/2015 | 225,000 |
Secor Alicia | Chief Commercial Officer | 09/17/2015 | 241,750 |
Secor Alicia | Chief Commercial Officer | 09/17/2015 | 1,077,809 |
KIM DENNIS D | Chief Medical Officer | 09/17/2015 | 14,353 |
KIM DENNIS D | Chief Medical Officer | 09/15/2015 | 47,516 |
KIM DENNIS D | Chief Medical Officer | 09/17/2015 | 365,680 |
KIM DENNIS D | Chief Medical Officer | 09/15/2015 | 1,210,600 |
KIM DENNIS D | Chief Medical Officer | 09/14/2015 | 931 |
KIM DENNIS D | Chief Medical Officer | 09/14/2015 | 23,720 |
Goldberg Avi Y. | Director | 06/10/2015 | 105,000 |
Goldberg Avi Y. | Director | 06/01/2015 | 64,452 |
STARR KEVIN P | Director | 01/08/2015 | 49,970 |
Booth Bruce | Director | 01/08/2015 | 34,995 |
Barrett Peter | Director | 01/08/2015 | 69,990 |
Secor Alicia | Chief Commercial Officer | 06/19/2014 | 80,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN LARIMAR THERAPEUTICS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 21,231,974 | 3.42% | 25.33% | Other |
BLACKROCK INC. | 1,668,045 | 0.00019% | 10.55% | Other |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,276,680 | 0.01% | 8.5% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 647,718 | 0.00031% | 5.1% | Other |
UBS OCONNOR LLC | 319,901 | 0.1% | -15.48% | Value |
RENAISSANCE TECHNOLOGIES LLC | 247,042 | 0.00174% | 0.69% | Other |
CHANGE IN SHARES OUTSTANDING FOR LARIMAR THERAPEUTICS INC
STOCK BUYBACKS FOR LARIMAR THERAPEUTICS INC
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.01%
1Q
06/30/2023
0.02%
2Q
03/31/2023
0.02%
3Q
BUYBACK ANNOUNCEMENT(S) FOR LARIMAR THERAPEUTICS INC
LOADING...